Pubblicazioni

Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: a systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, F.; Belgioia, L.; Alterio, D.; Bonomo, P.; Maddalo, M.; Paiar, F.; Denaro, N.; Corvo, R.; Merlotti, A.; Bossi, P.; Pappagallo, G. L.; D' Angelillo, R. M.; Magrini, S. M.; Arcangeli, S.

The safety of available treatments options for neuroendocrine tumors

2017 - EXPERT OPINION ON DRUG SAFETY

Faggiano, A.; Lo Calzo, F.; Pizza, G.; Modica, R.; Colao, A.

An overview of early investigational therapies for chemoresistant ovarian cancer

2015 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Marchetti, Claudia; Ledermann, Jonathan A.; BENEDETTI PANICI, Pierluigi